<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PONE-RA-04230R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0002572</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Genetics and Genomics/Cancer Genetics</subject><subject>Genetics and Genomics/Disease Models</subject><subject>Oncology/Breast Cancer</subject><subject>Oncology/Prostate Cancer</subject></subj-group></article-categories><title-group><article-title>A Role for Polyploidy in the Tumorigenicity of Pim-1-Expressing Human Prostate and Mammary Epithelial Cells</article-title><alt-title alt-title-type="running-head">Polyploidy in Tumorigenesis</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Roh</surname><given-names>Meejeon</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Franco</surname><given-names>Omar E.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hayward</surname><given-names>Simon W.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>van der Meer</surname><given-names>Riet</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Abdulkadir</surname><given-names>Sarki A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Bielinsky</surname><given-names>Anja-Katrin</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University of Minnesota, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>sarki.abdulkadir@vanderbilt.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: SA MR. Performed the experiments: MR OF Rv. Analyzed the data: SA MR Rv. Contributed reagents/materials/analysis tools: SH SA. Wrote the paper: SA MR.</p></fn></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>2</day><month>7</month><year>2008</year></pub-date><volume>3</volume><issue>7</issue><elocation-id>e2572</elocation-id><history><date date-type="received"><day>8</day><month>4</month><year>2008</year></date><date date-type="accepted"><day>22</day><month>5</month><year>2008</year></date></history><copyright-statement>Roh et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2008</copyright-year><abstract><sec><title>Background</title><p>Polyploidy is a prominent feature of many human cancers, and it has long been hypothesized that polyploidy may contribute to tumorigenesis by promoting genomic instability. In this study, we investigated whether polyploidy <italic>per se</italic> induced by a relevant oncogene can promote genomic instability and tumorigenicity in human epithelial cells.</p></sec><sec><title>Principal Findings</title><p>When the oncogenic serine-threonine kinase Pim-1 is overexpressed in immortalized, non-tumorigenic human prostate and mammary epithelial cells, these cells gradually converted to polyploidy and became tumorigenic. To assess the contribution of polyploidy to tumorigenicity, we obtained sorted, matched populations of diploid and polyploid cells expressing equivalent levels of the Pim-1 protein. Spectral karyotyping revealed evidence of emerging numerical and structural chromosomal abnormalities in polyploid cells, supporting the proposition that polyploidy promotes chromosomal instability. Polyploid cells displayed an intact p53/p21 pathway, indicating that the viability of polyploid cells in this system is not dependent on the inactivation of the p53 signaling pathway. Remarkably, only the sorted polyploid cells were tumorigenic <italic>in vitro</italic> and <italic>in vivo</italic>.</p></sec><sec><title>Conclusions</title><p>Our results support the notion that polyploidy can promote chromosomal instability and the initiation of tumorigenesis in human epithelial cells.</p></sec></abstract><counts><page-count count="11"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Aneuploidy is a common characteristic of human cancers and has been proposed as a driver of tumorigenesis <xref ref-type="bibr" rid="pone.0002572-Cahill1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Duesberg1">&#x0005b;2&#x0005d;</xref>. During tumor initiation, aneuploidy may arise via polyploidization where unstable tetraploid intermediates cause further chromosomal abnormalities including chromosomal gains, losses and translocations <xref ref-type="bibr" rid="pone.0002572-Ganem1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Ganem2">&#x0005b;4&#x0005d;</xref>. In human tumors, aneuploidy is found in pre-cancerous lesions of the cervix <xref ref-type="bibr" rid="pone.0002572-Ried1">&#x0005b;5&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002572-Olaharski1">&#x0005b;7&#x0005d;</xref>, head and neck <xref ref-type="bibr" rid="pone.0002572-Ai1">&#x0005b;8&#x0005d;</xref>, colon <xref ref-type="bibr" rid="pone.0002572-Ried1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Cardoso1">&#x0005b;9&#x0005d;</xref>, esophagus <xref ref-type="bibr" rid="pone.0002572-Doak1">&#x0005b;10&#x0005d;</xref> and prostate <xref ref-type="bibr" rid="pone.0002572-Pihan1">&#x0005b;11&#x0005d;</xref>. Nevertheless, the question of whether genomic instability is a driving force for cancer development, or a consequence of tumorigenesis has remained the subject of debate <xref ref-type="bibr" rid="pone.0002572-Marx1">&#x0005b;12&#x0005d;</xref>. A recent study by Fujiwara <italic>et al</italic> has provided experimental support for a role for polyploidy in tumorigenesis by using p53-null tetraploid mouse mammary epithelial cells <xref ref-type="bibr" rid="pone.0002572-Fujiwara1">&#x0005b;13&#x0005d;</xref>. These authors showed that tetraploid cells generated by transient treatment with a cytokinesis inhibitor, dihydrocytochalasin B, were tumorigenic in vivo. However, the impact of aneuploidy on tumorigenicity can be context dependent. In mice with reduced levels of the mitosis-specific, centromere-linked motor protein CENP-E, the resulting aneuploidy promotes tumorigenicity in some tissues while suppressing tumor development in others <xref ref-type="bibr" rid="pone.0002572-Weaver1">&#x0005b;14&#x0005d;</xref>. These findings underscore the importance of assessing the roles of chromosomal instability in tumorigenesis in specific cell types and animal species.</p><p>In the present study we have examined the question of whether polyploidy can promote tumorigenesis in human epithelial cells using a model of spontaneous polyploidy induced by the oncogene Pim-1. The Pim-1 oncogene is a serine-threonine kinase implicated in the development of various tumors including lymphomas and prostate carcinomas <xref ref-type="bibr" rid="pone.0002572-Dhanasekaran1">&#x0005b;15&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002572-Bachmann1">&#x0005b;17&#x0005d;</xref>. We have previously demonstrated that overexpression of Pim-1 in human prostate and breast epithelial cells results in the gradual emergence of polyploidy <xref ref-type="bibr" rid="pone.0002572-Roh1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Roh2">&#x0005b;19&#x0005d;</xref>. Notably, Pim-1 is abundantly expressed in the megakaryocyte lineage where it is involved in the regulation of polyploidy <xref ref-type="bibr" rid="pone.0002572-Jung1">&#x0005b;20&#x0005d;</xref>, suggesting that Pim-1 induced polyploidy in tumorigenesis might be a pathological manifestation of the same process. As the evolution of polyploidy in Pim-1 expressing cells is stochastic <xref ref-type="bibr" rid="pone.0002572-Roh2">&#x0005b;19&#x0005d;</xref>, this allowed us to obtained sorted Pim-1 expressing cells of the same passage that are either diploid or polyploid based on their DNA content. Our studies using these cells indicate that polyploidy induced by Pim-1 can promote the development of chromosomal abnormalities and tumorigenicity in human prostate and mammary epithelial cells.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Polyploid Pim-1-expressing RWPE1 Prostate Cells are Tumorigenic <italic>in Vivo</italic></title><p>To examine the oncogenic functions of Pim-1 in prostate epithelial cells, we stably overexpressed Pim-1 in immortalized, non-tumorigenic prostate epithelial RWPE1 cells (<xref ref-type="fig" rid="pone-0002572-g001">Figure 1A</xref>). As reported previously <xref ref-type="bibr" rid="pone.0002572-Roh1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Roh2">&#x0005b;19&#x0005d;</xref>, late passage RWPE1-Pim-1 cells are polyploid (tetraploid) as shown by FACS for DNA content and FISH, while early passage cells are diploid (<xref ref-type="fig" rid="pone-0002572-g001">Figures 1B, C</xref>). We injected these cells with matrigel into the flanks of nude mice subcutaneously to form xenografts. Analysis of the xenograft tissue indicates that only late passage RWPE1-Pim-1 cells formed small tumors (40&#x00025; incidence; n&#x0200a;&#x0003d;&#x0200a;10, average tumor volume&#x0200a;&#x0003d;&#x0200a;44.02&#x000b1;12.03 mm<sup>3</sup> at time of sacrifice) while both early and late passage control RWPE1-Neo cells (n&#x0200a;&#x0003d;&#x0200a;10 each) as well as early passage RWPE1-Pim-1 cells (n&#x0200a;&#x0003d;&#x0200a;10) only formed small benign looking glands (<xref ref-type="fig" rid="pone-0002572-g001">Figure 1D</xref>). Thus in this assay, tumorigenicity appears to depend on both Pim-1 expression and prolonged passage and/or polyploidy.</p><fig id="pone-0002572-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002572.g001</object-id><label>Figure 1</label><caption><title>Late passage, polyploid, Pim-1-expressing RWPE1 prostate cells are tumorigenic in nude mice.</title><p>(A) Western blotting for Pim-1 and actin in RWPE1 cells overexpressing Pim-1 or vector control (Neo). Early and late passage cells are shown. (B) Cell cycle profiles of Pim-1 overexpressing RWPE1 cells shows polyploidy in late passage cells. (C) FISH analysis of late passage Pim-1 overexpressing RWPE1 cells using probes for chromosomes 13 and 21 show chromosome doubling. (D) Sample images of H&#x00026;E stained sections from RWPE1 xenografts. Only late passage Pim-1 expressing cells were tumorigenic.</p></caption><graphic xlink:href="pone.0002572.g001"/></fig></sec><sec id="s2b"><title>Isolation of Matched Diploid/Polyploid Pim-1-expressing RWPE1 Cells by Cell Sorting</title><p>The results of our xenograft experiments suggested that polyploidy might have been a contributing factor in the tumorigenicity of late passage RWPE1-Pim-1 cells, since control non-polyploid RWPE1-Neo cells of the same late passage as well as early passage Pim-1-expressing cells were not tumorigenic. To directly investigate this, we took advantage of the gradual nature by which polyploidy arises in cultures of Pim-1-expressing cells. We have previously shown, using three different experimental approaches that all Pim-1-expressing cells have the potential to become polyploid, and do so in a stochastic manner <xref ref-type="bibr" rid="pone.0002572-Roh2">&#x0005b;19&#x0005d;</xref>. We sorted intermediate passage cells based on DNA content by FACS to obtain matched diploid (2N) and polyploid (&#x02265;4N) cell populations of the same passage (<xref ref-type="fig" rid="pone-0002572-g002">Figure 2A</xref>). After sorting, the cells stably maintained a diploid or tetraploid profile by FACS. Importantly, the expression levels of Pim-1 as well as those of several cell cycle and anti-apoptotic molecules (including Myc, Cyclin E, Cyclin D2, Bcl-2 and Bcl-<sub>XL</sub>) were similar in both diploid and polyploid cells (<xref ref-type="fig" rid="pone-0002572-g002">Figure 2B</xref>). Notably, Bcl-2, which is a known target of Pim-1 <xref ref-type="bibr" rid="pone.0002572-Lilly1">&#x0005b;21&#x0005d;</xref>, is upregulated in RWPE1-Pim-1 cells relative to control RWPE1-Neo cells; however the sorted RWPE1-Pim-1 diploid and polyploid cells expressed equivalent levels of Bcl-2 (<xref ref-type="fig" rid="pone-0002572-g002">Figure 2B</xref>). We found no significant differences in the proliferation rates of diploid and polyploid RWPE1-Pim-1 cells <italic>in vitro</italic> (<xref ref-type="fig" rid="pone-0002572-g002">Figure 2C</xref>).</p><fig id="pone-0002572-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002572.g002</object-id><label>Figure 2</label><caption><title>Isolation of matched diploid/polyploid RWPE1-Pim-1 cells by cell sorting.</title><p>(A) Diagram showing scheme for isolation of diploid (2N) and polyploid (&#x0003e;4N) Pim-1 cells by FACS sorting based on DNA content. Bottom panel is the FACS profile of sorted cells after several passages to get enough cells for FACS analysis. (B) Western blotting of Pim-1 and other markers in FACS sorted cells shows similar expression levels in sorted diploid and polyploid cells. (C) Cell counting of diploid and polyploid Pim-1 overexpressing cells. (D) Western blotting shows that the p53 pathway is intact in all FACS-sorted RWPE1 cells as demonstrated by the induction of p53 and p21 following daunorubicin treatment.</p></caption><graphic xlink:href="pone.0002572.g002"/></fig><p>Previous studies have suggested the existence of a p53-dependent checkpoint &#x02013;the &#x0201c;tetraploidy checkpoint&#x0201d;- that limits the proliferation of polyploid cells, although the existence of such a &#x0201c;tetraploidy checkpoint&#x0201d; has been contested <xref ref-type="bibr" rid="pone.0002572-Ganem2">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Uetake1">&#x0005b;22&#x0005d;</xref>. To determine if the p53 signaling pathway is inactivated in the sorted polyploid cells, we treated the cells with the chemotherapeutic agent daunorubicin. We observed stabilization of p53 as well as the induction of its target molecule, p21 after daunorubicin treatment, indicating that the p53 pathway is intact in these cells (<xref ref-type="fig" rid="pone-0002572-g002">Figure 2D</xref>). This may appear surprising since RWPE1 cells were immortalized by human papillomavirus type 18 (HPV-18) and the E6 protein of HPV-18 is known to interfere with p53 function <xref ref-type="bibr" rid="pone.0002572-Thomas1">&#x0005b;23&#x0005d;</xref>. Nevertheless, it has been reported that the p53 pathway is functional in certain HPV-immortalized cell lines <xref ref-type="bibr" rid="pone.0002572-Butz1">&#x0005b;24&#x0005d;</xref>, consistent with our results.</p></sec><sec id="s2c"><title>Chromosomal Abnormalities in Polyploid RWPE1-Pim-1 Cells</title><p>To gain further insight into the genomic alterations in polyploid cells, we performed karyotype analyses. Spectral karyotyping (SKY) showed that 100&#x00025; of the control RWPE1-Neo (n&#x0200a;&#x0003d;&#x0200a;40) and diploid RWPE1-Pim-1 cells (n&#x0200a;&#x0003d;&#x0200a;31) cells examined were near-diploid, containing between 45 and 50 chromosomes per cell (<xref ref-type="fig" rid="pone-0002572-g003">Figures 3A, B</xref>). By contrast, a majority of the polyploid RWPE1-Pim-1 cells (81&#x00025;, n&#x0200a;&#x0003d;&#x0200a;31) were near-tetraploid, containing 91&#x02013;100 chromosomes. Apart from whole-chromosomal gains, Pim-1 polyploid cells exhibited a wide range of both numerical and structural aberrations including chromosomal translocations and deletions (<xref ref-type="fig" rid="pone-0002572-g003">Figures 3B, C</xref>), whereas control Neo and Pim-1 diploid cells had fewer structural abnormalities and numerical variations. Although the number of structural chromosomal aberrations per cell in polyploid cells was approximately twice that in control Neo or diploid cells, the number of structural chromosomal aberrations per chromosome was almost the same in all groups (<xref ref-type="supplementary-material" rid="pone.0002572.s002">Figure S1</xref>), suggesting that the higher chromosome number in polyploid cells is a primary factor in the increase in chromosomal abnormalities observed. Nevertheless, although a majority of polyploid cells shared the same chromosomal translocation and deletion with control Neo and diploid cells, attesting to their common origin, there were also several polyploid cell-specific chromosomal translocations and deletions present in various fractions of the polyploid cells (<xref ref-type="fig" rid="pone-0002572-g003">Figure 3C</xref>). These results indicate the presence of chromosomal instability and the emergence of aneuploidy in the sorted polyploid cells.</p><fig id="pone-0002572-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002572.g003</object-id><label>Figure 3</label><caption><title>Chromosomal abnormalities in sorted polyploid RWPE1-Pim-1 cells.</title><p>(A) Percentage of cells showing total chromosome number, numerical and structural aberrations from FACS-sorted RWPE1 cells. Total 31 to 40 metaphase spreads were analyzed per sample and scored for the chromosome number, numerical aberrations, and structural aberrations. (B) Representative SKY images of sorted Neo, diploid and polyploid RWPE1-Pim-1 cells. Neo: 49,X,del(Y),&#x0002b;5, t(9;20;X),t(11;18),&#x0002b;12,del(12),t(12;21),t(14;18),&#x0002b;15,t(14;18),&#x0002b;20,t(18;20). Diploid: 49,X,del(Y),t(3;4),&#x0002b;5,&#x0002b;5,t(9;20;9),&#x0002b;12,t(5;12)(12;21),t(14;18),t(7;18),&#x0002b;20,t(17;18;20). Polyploid: 97,XX,del(Y),&#x0002b;1,&#x0002b;1,&#x0002b;1,t(1;5),&#x0002b;2,&#x0002b;2,&#x0002b;3,&#x0002b;3,&#x0002b;3,t(3;7),&#x0002b;4,&#x0002b;4,&#x0002b;5,&#x0002b;5,&#x0002b;5,&#x0002b;5,&#x0002b;5,&#x0002b;5,t(5;21),&#x0002b;6,&#x0002b;6,&#x0002b;7,&#x0002b;8,&#x0002b;8,&#x0002b;9,&#x0002b;9,t(9;20;9)&#x000d7;2,&#x0002b;10,&#x0002b;10,&#x0002b;11,&#x0002b;11,&#x0002b;12,&#x0002b;12,&#x0002b;12,&#x0002b;12,t(5;12)&#x000d7;2(12;21)&#x000d7;2,&#x0002b;13,&#x0002b;13,&#x0002b;14,&#x0002b;14,t(14;18)&#x000d7;2,&#x0002b;15,&#x0002b;15,&#x0002b;16,&#x0002b;16,&#x0002b;17,&#x0002b;17,&#x0002b;18,&#x0002b;18,t(7;18)&#x000d7;2,&#x0002b;19,&#x0002b;19,&#x0002b;20,&#x0002b;20,&#x0002b;20,&#x0002b;20,t(17;18;20)&#x000d7;2,&#x0002b;21,&#x0002b;22. (C) Table showing structural chromosomal aberrations. The numbers of derivative chromosomes observed are shown. Polyploid-specific abnormalities are shown in bold.</p></caption><graphic xlink:href="pone.0002572.g003"/></fig></sec><sec id="s2d"><title>Sorted, Polyploid RWPE1 Prostate Cells are Tumorigenic <italic>in Vitro</italic> and <italic>in Vivo</italic></title><p>We next examined the role of polyploidy and the ensuing chromosomal instability in the <italic>in vitr</italic>o tumorigenicity of RWPE1-Pim-1 cells by assessing the ability of sorted cells to grow in an anchorage-independent manner in soft agar. As shown in <xref ref-type="fig" rid="pone-0002572-g004">Figure 4A</xref>, only polyploid RWPE1-Pim-1 cells formed colonies in soft agar, despite the fact that the expression levels of Pim-1 are similar in both diploid and polyploid cells as noted earlier in <xref ref-type="fig" rid="pone-0002572-g002">Figure 2B</xref> and these cells were carried for the same passage. These data indicate that Pim-1 expression alone is insufficient to promote growth in soft agar and that polyploidy (and the resultant genomic instability) can cooperate with Pim-1 to promote the tumorigenicity of prostate epithelial cells. To determine if genomic instability due to polyploidy can promote tumorigenesis <italic>in vivo</italic>, we performed tissue recombination experiments. Human prostate epithelium is known to have the ability to generate prostate gland-like structures when combined with rat urogenital mesenchyme (UGM) and implanted under the renal capsule of immune-deficient mice <xref ref-type="bibr" rid="pone.0002572-Hayward1">&#x0005b;25&#x0005d;</xref>. We combined the sorted diploid and polyploid RWPE1-Pim-1 as well as control RWPE1-Neo cells with UGM and grafted them under the renal capsule of immune-deficient mice.</p><fig id="pone-0002572-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002572.g004</object-id><label>Figure 4</label><caption><title>Polyploidy promotes the tumorigenicity of RWPE1 prostate cells <italic>in vitro</italic> and <italic>in vivo</italic>.</title><p>(A) Soft agar assay with colony counting in FACS-sorted RWPE1 cells. Colonies larger than 0.5 mm in diameter were counted. Results represent average of triplicate experiments. &#x0002a;p&#x0003c;0.05. (B) Histological analysis of grafts of diploid and polyploid RWPE1-Pim-1 cells recombined with rat UGM and grafted under the kidney capsule. Grafts from polyploid cells contained foci of carcinoma-in-situ with loss of the basal cell marker p63 and high rates of mitotic cells (p-HH3, phospho-histone H3) while diploid cells formed largely small benign looking glands that express p63 and low rates of mitosis (p-HH3). A human-specific Ku70 antibody was used to confirm the human origin of glands. All images were taken at the same magnification of 4&#x000d7;.</p></caption><graphic xlink:href="pone.0002572.g004"/></fig><p>Twelve weeks after grafting, all of the grafts from control Neo (n&#x0200a;&#x0003d;&#x0200a;4) and diploid cells (n&#x0200a;&#x0003d;&#x0200a;8) formed largely normal looking, benign gland structures. However, 3 of 8 grafts from polyploid cells contained foci of carcinoma in situ (<xref ref-type="fig" rid="pone-0002572-g004">Figure 4B</xref>) with evidence of loss of the basal cell marker p63 and increased levels of mitosis as shown by staining for phospho-histone H3 (<xref ref-type="fig" rid="pone-0002572-g004">Figure 4B</xref>). To confirm the RWPE1 origin of the glands, human-specific Ku70 staining was used. Taken together, these results indicate that polyploidy induced by Pim-1 promotes genomic instability which contributes to tumorigenicity.</p></sec><sec id="s2e"><title>Polyploid, Pim-1-expressing Telomerase-Immortalized Mammary Epithelial Cells are Tumorigenic</title><p>We next sought to determine if the role of Pim-1-induced polyploidy in promoting genomic instability and tumorigenicity extends to other human cell types. In addition, we wanted to examine this phenomenon in cells immortalized through means other than an oncogenic virus (i.e. HPV). We used hTERT-HME1 cells which are non-tumorigenic human mammary epithelial cells immortalized by expression of the human telomerase catalytic subunit, hTERT. Similar to our findings with the RWPE1 prostate cells, we observed that only polyploid, late passage Pim-1 expressing hTERT-HME1 cells formed colonies in soft agar (<xref ref-type="supplementary-material" rid="pone.0002572.s003">Figure S2</xref>). Next, we isolated matched diploid/polyploid Pim-1-expressing hTERT-HME1 cells of the same passage by cell sorting. The FACS profile of sorted cells showed that Pim-1 diploid and control Neo derived-cells maintained diploid DNA content, whereas Pim-1 polyploid cells were almost exclusively tetraploid (<xref ref-type="fig" rid="pone-0002572-g005">Figure 5A</xref>). The expression levels of Pim-1 as well as Myc were comparable in both the diploid and polyploid hTERT-HME1 cells (<xref ref-type="fig" rid="pone-0002572-g005">Figure 5B</xref>). We observed a modest increase in Cyclin E in the polyploid cells, which may be related to the increased proliferation rate of the hTERT-HME1-derived polyploid cells <italic>in vitro</italic> (<xref ref-type="fig" rid="pone-0002572-g005">Figure 5C</xref>). This contrasts with the case for RWPE1-derived polyploid cells which displayed comparable proliferation rate relative to their diploid counterparts. Furthermore, we examined the expression of various cell markers in polyploid cells including early progenitor cell markers CD44, nestin and cytokeratin 5 by immunofluorescence. We found no significant differences between diploid and polyploid cells (<xref ref-type="supplementary-material" rid="pone.0002572.s004">Figure S3</xref>). We also probed the p53 pathway in hTERT-HME1-derived polyploid cells by treating the cells with daunorubicin followed by western blotting for p53 and p21. The results indicate that as in the polyploid RWPE1-derived cells this pathway is intact in the hTERT-HME1 cells (<xref ref-type="fig" rid="pone-0002572-g005">Figure 5D</xref>). Thus the viability of the polyploid cells examined here does not appear to depend on the inactivation of p53. Since Pim-1 has pro-survival functions, it may substitute for p53 loss in promoting the viability of emerging polyploid cells.</p><fig id="pone-0002572-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002572.g005</object-id><label>Figure 5</label><caption><title>FACS sorted, Polyploid, Pim-1 expressing telomerase-immortalized mammary epithelial cells (hTERT-HME1) are tumorigenic <italic>in vitro</italic>.</title><p>(A) FACS profile after cell sorting. hTERT-HME1 cells were sorted based on DNA content. (B) Western blotting of Pim-1 and other markers in sorted cells. Pim-1 expression levels are similar in diploid and polyploid cells. (C) Cell counting of Neo control, diploid and polyploid Pim-1 overexpressing cells. (D) Western blotting for p21 and p53 after daunorubicin treatment shows that p53 function is intact in all FACS-sorted hTERT-HME1 cells.</p></caption><graphic xlink:href="pone.0002572.g005"/></fig></sec><sec id="s2f"><title>Chromosomal Abnormalities in Polyploid hTERT-HME1 Cells</title><p>The karyotypes of control Neo and diploid Pim-1-hTERT-HME1 cells were stable and uniform with few numerical and structural abnormalities (<xref ref-type="fig" rid="pone-0002572-g006">Figure 6</xref>). All of the Neo control cells examined (n&#x0200a;&#x0003d;&#x0200a;40) and almost all of the diploid Pim-1 cells (39 of 40) were diploid or near-diploid, containing between 45 and 48 chromosomes. In contrast, all polyploid cells (n&#x0200a;&#x0003d;&#x0200a;13) contained 79 to 89 chromosomal numbers, indicative of near-tetraploidy (<xref ref-type="fig" rid="pone-0002572-g006">Figure 6A</xref>). The observed chromosome numbers in the polyploid cells (79&#x02013;89 chromosomes) are lower than the predicted doubling of the number of chromosomes in the Neo/Diploid cells (90&#x02013;98 chromosomes). This suggests that sub-tetraploid cell population could be derived either from tetraploid cells by ongoing chromosomal loss, or from the diploid population by unknown mechanisms. Furthermore, the polyploid cells displayed significantly more structural chromosomal abnormalities than the control cells (<xref ref-type="fig" rid="pone-0002572-g006">Figures 6A&#x02013;C</xref>). To gain additional insights into the evolution of tumorigenic subpopulations among polyploid cells, we isolated and cultured cells from soft agar colonies derived from polyploid cells &#x0005b;see <xref ref-type="fig" rid="pone-0002572-g007">Figure 7A</xref> below&#x0005d;. By SKY analysis, soft agar-derived cells displayed increased numerical and structural aberrations similar to the polyploid cells (<xref ref-type="fig" rid="pone-0002572-g006">Figures 6A&#x02013;C</xref>). In addition, the numbers of structural chromosomal aberrations per chromosome were higher in the polyploid and soft agar-derived cells compared to the control Neo or diploid cells (<xref ref-type="supplementary-material" rid="pone.0002572.s002">Figure S1</xref>). These results suggest that the chromosomal abnormalities seen in these cells are not merely due to increased chromosomal numbers but are due to active chromosomal instability. Notably, 7 out of 25 of the soft agar-derived cells examined contained a unique chromosomal translocation, t(8;20), providing further evidence of chromosomal instability in the evolution of tumorigenic populations (<xref ref-type="fig" rid="pone-0002572-g006">Figure 6C</xref>).</p><fig id="pone-0002572-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002572.g006</object-id><label>Figure 6</label><caption><title>Chromosomal abnormalities in polyploid hTERT-HME1 cells.</title><p>(A) Percentage of cells showing total chromosome number, numerical and structural aberrations from FACS-sorted hTERT-HME1 cells. Note that karyotypes of polyploid and soft agar derived cells are highly heterogeneous, whereas karyotypes of control Neo and diploid cells are more uniform. Total 13 to 40 metaphase spreads were analyzed per sample and scored for the chromosome number, numerical aberrations, and structural aberrations. (B) Representative SKY images from each FACS-sorted hTERT-HME1 cells. Neo: 45,XX,t(6;17),&#x02212;17. Diploid: 46,XX,del(5),t(5;8). Polyploid: 89,XXXX,&#x0002b;1,&#x0002b;1,t(1;2),&#x0002b;2,&#x0002b;3,&#x0002b;3,&#x0002b;4,&#x0002b;5,&#x0002b;5,&#x0002b;5,del(5),&#x0002b;6,&#x0002b;6,&#x0002b;7,&#x0002b;7,&#x0002b;8,&#x0002b;8,&#x0002b;9,&#x0002b;9,&#x0002b;10,&#x0002b;10,&#x0002b;11,&#x0002b;11,del(11),&#x0002b;12,&#x0002b;12,&#x0002b;13,&#x0002b;13,&#x0002b;14,&#x0002b;15,&#x0002b;15,&#x0002b;16,&#x0002b;16,&#x0002b;17,&#x0002b;17,t(15;17),&#x0002b;18,&#x0002b;18,&#x0002b;19,&#x0002b;19,&#x0002b;20,&#x0002b;20,&#x0002b;21,&#x0002b;21,&#x0002b;22. Soft agar: 89,XXX,&#x0002b;1,&#x0002b;1,t(1;2),&#x0002b;2,&#x0002b;3,&#x0002b;3,&#x0002b;4,&#x0002b;5,&#x0002b;5,&#x0002b;5,del(5), &#x0002b;6,&#x0002b;6,&#x0002b;7,&#x0002b;7,&#x0002b;8,&#x0002b;8,&#x0002b;8,t(8;20),&#x0002b;9,&#x0002b;9,&#x0002b;10,&#x0002b;10,&#x0002b;11,&#x0002b;11,del(11),&#x0002b;12,&#x0002b;12,&#x0002b;13,&#x0002b;13,&#x0002b;14,&#x0002b;14,&#x0002b;15,&#x0002b;16,&#x0002b;16,&#x0002b;17,&#x0002b;17,&#x0002b;18,&#x0002b;18,&#x0002b;19,&#x0002b;19,&#x0002b;20,&#x0002b;21,&#x0002b;21,&#x0002b;22,&#x0002b;22. (C) Tables showing derivative chromosomes in the different sorted cell types. The numbers of derivative chromosomes observed are shown. Polyploid and soft agar derived cell-specific abnormalities are shown in bold.</p></caption><graphic xlink:href="pone.0002572.g006"/></fig><fig id="pone-0002572-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0002572.g007</object-id><label>Figure 7</label><caption><title>Polyploidy promotes the tumorigenicity of hTERT-HME1 cells.</title><p>Soft agar assay of FACS-sorted diploid and polyploid hTERT-HME1 Pim-1 overexpressing cells and control Neo cells. Note the larger colonies in polyploid cells. Colonies larger than 1 mm in diameter were counted from triplicate of 60 mm dishes. Original magnification: 10&#x000d7;. (B) We isolated cells from soft agar colonies formed by polyploid cells shown in <xref ref-type="fig" rid="pone-0002572-g007">Fig. 7A</xref>. The tumorigenic potential of these soft agar-derived polyploid cells was compared side by side with that of the parental polyploid cells by soft agar assay. The soft agar-derived cells formed larger size colonies with higher frequency than the parental polyploid cell population. Original magnification; 4&#x000d7;.</p></caption><graphic xlink:href="pone.0002572.g007"/></fig></sec><sec id="s2g"><title>Sorted, Polyploid hTERT-HME1 Mammary Cells are Tumorigenic</title><p>The tumorigenicity of the sorted hTERT-HME1 cells was tested by anchorage-independent growth in soft agar. Polyploid cells formed robust colonies in soft agar (<xref ref-type="fig" rid="pone-0002572-g007">Figure 7A</xref>), unlike the diploid or Neo control cells, indicating that the pro-tumorigenic effect of Pim-1-induced polyploidy extends to different cell types. Furthermore, the soft agar derived cells formed larger sized colonies with higher frequency than polyploid cells, suggesting more tumorigenic potential of these cells (<xref ref-type="fig" rid="pone-0002572-g007">Figure 7B</xref>).</p></sec></sec><sec id="s3"><title>Discussion</title><p>In this study we demonstrated that polyploidy, induced by the oncogenic kinase Pim-1 can promote the development of aneuploidy and tumorigenicity in human epithelial cells. Using genetically matched FACS-sorted diploid and polyploid prostate and mammary epithelial cells, we demonstrated that only the polyploid cells were tumorigenic despite the fact that they expressed equivalent levels of the Pim-1 oncogene. Thus, Pim-1 overexpression itself in the absence of polyploidy is not sufficient for tumorigenicity in our experimental system. We also provide evidence that the tumorigenicity of polyploid cells is likely due to the intrinsic chromosomal instability present in these cells including whole-chromosome gains/losses as well as structural abnormalities including deletions and translocation. Furthermore, our data demonstrated that the survival of polyploid cells is not dependent on inactivation of the p53 pathway, suggesting that Pim-1 might substitute for p53 loss.</p><p>Genomic instability is a hallmark of human cancer and a majority of carcinomas display gross chromosomal abnormalities. It is thought that polyploidization (specifically tetraploidy) may represent an important intermediate step in tumor initiation via its ability to catalyze the development of additional chromosomal abnormalities due to segregation errors that result from having multiple centrosomes and extra chromosomes <xref ref-type="bibr" rid="pone.0002572-Ganem1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Duesberg2">&#x0005b;26&#x0005d;</xref>. The diverse chromosomal landscape of the resulting cells may then provide a permissive substrate on which selective forces can act to mould the development of a tumor. In prostate cancer, abnormal diploid cancers may represent an early stage in ploidy progression and DNA ploidy abnormalities occur in benign prostatic tissue adjacent to many prostate cancers <xref ref-type="bibr" rid="pone.0002572-Forsslund1">&#x0005b;27&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Deitch1">&#x0005b;28&#x0005d;</xref>. In breast cancer, there is also a correlation between aneuploidy and tumor progression <xref ref-type="bibr" rid="pone.0002572-Mendelin1">&#x0005b;29&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0002572-Ottesen1">&#x0005b;31&#x0005d;</xref>. However, despite the correlation between aneuploidy and tumorigenicity, direct tests for the role of aneuploidy in tumor development have been difficult partly due to the lack of suitable experimental systems, especially those consisting of human cells. One of the more direct tests of the role of tetraploidy in promoting tumorigenicity relied on chemical treatment with a cytokinesis inhibitor, dihydrocytochalasin B (DCB), to induce tetraploidy in p53-null mouse mammary epithelial cells (MMECs) <xref ref-type="bibr" rid="pone.0002572-Fujiwara1">&#x0005b;13&#x0005d;</xref>. In this study, the authors demonstrated that tetraploidy can promote chromosomal instability and tumorigenesis. Our data are consistent with this conclusion. However our system differs in several respects from the MMEC model: (i) We employed human epithelial cells, which are difficult to transform <xref ref-type="bibr" rid="pone.0002572-Elenbaas1">&#x0005b;32&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Woo1">&#x0005b;33&#x0005d;</xref>. (ii) The development of polyploidy in our system is spontaneous, following the expression of an oncogene, Pim-1. As many cancer-related genes have been linked to the development of polyploidy, for example MYC <xref ref-type="bibr" rid="pone.0002572-Li1">&#x0005b;34&#x0005d;</xref>, APC <xref ref-type="bibr" rid="pone.0002572-Dikovskaya1">&#x0005b;35&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Caldwell1">&#x0005b;36&#x0005d;</xref>, Pim-1 <xref ref-type="bibr" rid="pone.0002572-Roh1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Roh2">&#x0005b;19&#x0005d;</xref>, BRCA2 <xref ref-type="bibr" rid="pone.0002572-Sagulenko1">&#x0005b;37&#x0005d;</xref>, and Aurora-A <xref ref-type="bibr" rid="pone.0002572-Wang1">&#x0005b;38&#x0005d;</xref>, our model may reflect an actual pathway for tumor initiation. (iii) In our system, polyploid cells arise in the face of an intact p53 pathway, whereas p53<sup>&#x0002b;/&#x0002b;</sup> tetraploid MMECs did not survive <xref ref-type="bibr" rid="pone.0002572-Fujiwara1">&#x0005b;13&#x0005d;</xref>. It has been reported that p53 loss facilitates the formation of tetraploidy and the survival of cells with genomic instability <xref ref-type="bibr" rid="pone.0002572-Yin1">&#x0005b;39&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Minn1">&#x0005b;40&#x0005d;</xref>.</p><p>Some studies posit the existence of a p53-dependent checkpoint that prevents the propagation of tetraploid cells <xref ref-type="bibr" rid="pone.0002572-Andreassen1">&#x0005b;41&#x0005d;</xref>, while other studies have questioned the existence of such a &#x0201c;tetraploidy checkpoint&#x0201d; <xref ref-type="bibr" rid="pone.0002572-Ganem2">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Uetake1">&#x0005b;22&#x0005d;</xref>. Nevertheless, tetraploid cells appear to be generally less fit than diploid cells. For example tetraploid cells are reported to have an elevated rate of spontaneous apoptosis that is dependent on p53 expression <xref ref-type="bibr" rid="pone.0002572-Castedo1">&#x0005b;42&#x0005d;</xref>. Importantly, Pim-1 has been reported to enhance cell survival through upregulation of Bcl-2 <xref ref-type="bibr" rid="pone.0002572-Lilly1">&#x0005b;21&#x0005d;</xref>, as well as inactivation of the pro-apoptotic Bad protein by phosphorylation <xref ref-type="bibr" rid="pone.0002572-Aho1">&#x0005b;43&#x0005d;</xref>. Therefore, it is possible that Pim-1, with its pro-survival functions, substitutes for p53 loss to allow for the survival of polyploid cells in our system.</p><p>Further analyses of polyploid cells before and after tumor formation are required to gain additional insights into the promotion of tumorigenesis by polyploidy. Nevertheless, it is interesting to note that the aneuploidy hypothesis predicts long latency for tumorigenesis as well as clonality. If the driving force for tumorigenesis is the inherent aneuploid karyotype initiated by a carcinogen or arising spontaneously, the resulting chromosomal instability will promote the appearance of preneoplastic and eventually neoplastic karyotypes. The generation of a neoplastic cell species will be expected to be slow and thus clonal <xref ref-type="bibr" rid="pone.0002572-Duesberg2">&#x0005b;26&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Li2">&#x0005b;44&#x0005d;</xref>. Tumorigenicity induced by polyploidy may also follow divergent routes depending on the particular karyotype generated. Consistent with this notion, the polyploid prostate and mammary epithelial cells we generated displayed very distinctive karyotypes although both cells were tumorigenic. They displayed some phenotypic differences as well. The RWPE-Pim-1 polyploid cells had a similar <italic>in vitro</italic> proliferation rate compared to their diploid counterparts while hTERT-HME1-Pim-1 polyploid cells proliferated at a much faster rate than the diploid cells.</p><p>In summary, our results provide evidence that polyploidy, by promoting the development of aneuploidy, is a promoter of tumorigenesis in human cells. This fact, coupled with the observation that many human tumors exhibit polyploidy, make polyploid cells attractive targets for novel therapeutics.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Cells, Animals, and Reagents</title><p>RWPE1 prostate and hTERT-HME1 mammary cell lines stably expressing Pim-1 were generated as described <xref ref-type="bibr" rid="pone.0002572-Roh1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Roh2">&#x0005b;19&#x0005d;</xref>. Early, middle and late passage cells are defined based on the appearance of polyploidy upon in vitro culture as described previously <xref ref-type="bibr" rid="pone.0002572-Roh2">&#x0005b;19&#x0005d;</xref>; early passage 1&#x02013;20; middle passage 25&#x02013;40; late passage &#x0003e;40. Six to eight week old athymic nude mice, male severe combined immunodeficient (SCID) mice &#x0005b;C.B.17/IcrHsd-scid&#x0005d;, and pregnant Sprague-Dawley rats were obtained from NCI-Fredrick, The Jackson Laboratory or Harlan Laboratory, respectively. Antibodies used for western blotting include anti-Pim-1 (12H8), Myc (9E10), Cyclin E (M-20), Cyclin D2 (C-17), Bcl-2 (100), Bcl-<sub>XL</sub> (H-5), p53 (DO-1), p21 (F-5) and actin (C-11) (all from Santa Cruz Biotechnology). Antibodies against p63 (PPM 201 AA, H, Biocare Medical), phospho-histone H3 S10 (06-570, Upstate), and Ku 70 (as10878, abcam) were used for immunostaining.</p></sec><sec id="s4b"><title>Flow Cytometric Analysis</title><p>Cells were fixed with 70&#x02013;100&#x00025; cold ethanol and DNA was stained with propidium iodide for analysis as described <xref ref-type="bibr" rid="pone.0002572-Roh1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Roh2">&#x0005b;19&#x0005d;</xref>. Sorting of cells based on DNA content was performed as described <xref ref-type="bibr" rid="pone.0002572-Roh2">&#x0005b;19&#x0005d;</xref>. Briefly, intermediate passage (passage 25) cells were stained with 5 ug/ml of Hoechst 33342 (Sigma-Aldrich) for 90 min at 37&#x000b0;C and sorted according to DNA content (2N, 4N, and &#x0003e;4N) using a cell sorter. Diploid (2N DNA) and polyploid (&#x0003e;4N DNA) cells were used for our experiments. 4N DNA cells were not used since this is the mixed population of G2/M phase of 2N DNA cells and G1 phase of &#x0003e;4N DNA cells.</p></sec><sec id="s4c"><title>Western Blotting and Immunohistochemistry</title><p>For western blot analysis, total cell lysates and samples were prepared and processed as described <xref ref-type="bibr" rid="pone.0002572-Roh1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0002572-Roh2">&#x0005b;19&#x0005d;</xref> with the indicated antibodies. For daunorubicin treatment, both RWPE-1 or hTERT-HME1 cells were treated with 0.5 &#x000b5;m daunorubicin (Sigma-Aldrich, D8809) for 6 and 24 h, and total cell lysates were prepared for western blotting. Immunohistochemistry was carried out as previously described <xref ref-type="bibr" rid="pone.0002572-Abdulkadir1">&#x0005b;45&#x0005d;</xref>.</p></sec><sec id="s4d"><title>Soft Agar Assays</title><p>These were carried out as described <xref ref-type="bibr" rid="pone.0002572-Mogal1">&#x0005b;46&#x0005d;</xref>. Briefly, 10<sup>4</sup> cells were mixed with 0.3&#x00025; soft agar and plated on top of 0.6&#x00025; bottom agar seeded on each of a 60 mm plate. Triplicate plating was carried out for each sample. The cells were incubated at 37&#x000b0;C for 2 weeks to allow colony formation, and stained with 0.05&#x00025; crystal violet for colony counting. Images were captured with a Leica DM IRB inverted wide field microscope with a Nikon DXM1200C camera.</p></sec><sec id="s4e"><title>Xenograft and Tissue Recombination Assays</title><p>For xenografts, 3&#x000d7;10<sup>6</sup> RWPE1 cells were mixed with 400 &#x000b5;l of matrigel and injected into 6&#x02013;8 week old athymic nude mice subcutaneously. Mice were sacrificed after 8 months for histological analysis. Tumor size was measured with calipers and the histology of all samples was examined after sacrifice. For tissue recombination, 10<sup>5</sup> sorted RWPE1-Pim-1 as well as control RWPE1-Neo cells were recombined with 2.5&#x000d7;10<sup>5</sup> rat urogenital mesenchyme (UGM) and suspended in rat tail collagen (50 &#x000b5;L/graft). Rat collagen was prepared as described previously <xref ref-type="bibr" rid="pone.0002572-Hayward1">&#x0005b;25&#x0005d;</xref>. Briefly, tails from mature rats were taken and soaked in 70&#x00025; ethanol, and then the skin was split at the tail root and peeled away. The tails were cut away and each tendon was teased to separate the fiber. Then tendons were transferred to acetic acid, centrifuge, and stored at 4&#x000b0;C until use. Rat UGM was prepared from 18-day embryonic fetuses. Urogenital sinuses were dissected from fetuses and separated into epithelial and mesenchymal components by tryptic digestion as described previously <xref ref-type="bibr" rid="pone.0002572-Hayward1">&#x0005b;25&#x0005d;</xref>. Single cells of UGM were then prepared by a 90-min digestion at 37&#x000b0;C with 187 units/ml collagenase (Gibco-BRL). The recombinants were incubated overnight in a 5&#x00025; CO<sub>2</sub> humidified incubator at 37&#x000b0;C in RPMI1640 and subsequently placed beneath the renal capsule of male athymic mice. Testosterone pellets were implanted dorsally under the skin of SCID mice. 12 weeks after grafting, the hosts were sacrificed. Harvested grafts were fixed in paraffin and embedded for histological and immunohistochemical analysis as described <xref ref-type="bibr" rid="pone.0002572-Abdulkadir1">&#x0005b;45&#x0005d;</xref>. Experiments were performed according to the protocols approved by the Institutional Animal Care and Use Committees at the University of Alabama at Birmingham and at Vanderbilt University.</p></sec><sec id="s4f"><title>Fluorescence in situ hybridization (FISH) and Spectral Karyotyping (SKY)</title><p>For FISH, cells were prepared and processed as described <xref ref-type="bibr" rid="pone.0002572-Weaver1">&#x0005b;14&#x0005d;</xref>. SKY analysis was done as described <xref ref-type="bibr" rid="pone.0002572-Karpf1">&#x0005b;47&#x0005d;</xref> and was carried out at the Roswell Park Cancer Institute SKY Analysis Facility. Briefly, the metaphase chromosomes were prepared by treatment cells with either Colcemid at 0.06 &#x000b5;g/ml or Nocodazole at 0.5 &#x000b5;g/ml for 2&#x02013;4 hr. The SKY-DAPI images were captured using a Nikon microscope equipped with a Spectral cube and Interferometer module. Spectral karyotypes were prepared using SKY View software (Version 1.62). Numerical chromosomal abnormalities were determined based on the deviation from 46 (for diploid cells) or 92 (for tetraploid cells) chromosomes per cell.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0002572.s001"><label>Methods S1</label><caption><p>Immunofluorescence methods for <xref ref-type="supplementary-material" rid="pone.0002572.s004">Figure S3</xref>.</p><p>(0.03 MB DOC)</p></caption><media xlink:href="pone.0002572.s001.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0002572.s002"><label>Figure S1</label><caption><p>The relationship of chromosomal abnormalities to the number of chromosomes. The number of structural chromosomal aberrations per cell or per chromosome was plotted with the data presented in <xref ref-type="fig" rid="pone-0002572-g003">Figure 3</xref> (RWPE1 cells) and <xref ref-type="fig" rid="pone-0002572-g006">Figure 6</xref> (hTERT-HME1 cells).</p><p>(1.04 MB TIF)</p></caption><media xlink:href="pone.0002572.s002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0002572.s003"><label>Figure S2</label><caption><p>Late passage, polyploid, Pim-1 expressing hTERT-HME1 cells are tumorigenic in vitro. (A) Western blot for Pim-1 in early and late passage human telomerase immortalized mammary epithelial (hTERT-HME1) cells stably expressing Pim-1. (B) Cell cycle profile of Pim-1 overexpressing hTERT-HME1 cells. (C) Soft agar assay of hTERT-HME1-Pim-1 cells. (D) Soft agar colonies larger than 1 mm in diameter were counted from 60 mm dishes. The data represent the average from triplicate experiments. &#x0002a;p&#x0003c;0.05.</p><p>(1.76 MB TIF)</p></caption><media xlink:href="pone.0002572.s003.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0002572.s004"><label>Figure S3</label><caption><p>Expression of cell markers in sorted diploid and polyploid-hTERT-HME1 cells. Expression level for CD44, cytokeratin 5, and nestin were examined by immunofluorescence in diploid and polyploid hTERT-HME1 cells. There are no significant differences between these two cells. Inset, higher magnification image of nestin stain.</p><p>(2.87 MB TIF)</p></caption><media xlink:href="pone.0002572.s004.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Dr. Chisu Song of Vanderbilt University for critical reading of the manuscript and helpful discussions, Dr. Isam-Eldin Eltoum of the University of Alabama at Birmingham for reviewing tissue samples of xenograft studies, Dr. Sei-ichi Matsui of the Roswell Park Cancer Institute SKY analysis facility for spectral karyotyping analysis, and Irina Doubinskaia for technical assistance.</p></ack><ref-list><title>References</title><ref id="pone.0002572-Cahill1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cahill</surname><given-names>DP</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Lengauer</surname><given-names>C</given-names></name></person-group><year>1999</year><article-title>Genetic instability and darwinian selection in tumours.</article-title><source>Trends Cell Biol</source><volume>9</volume><fpage>M57</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">10611684</pub-id></citation></ref><ref id="pone.0002572-Duesberg1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duesberg</surname><given-names>P</given-names></name></person-group><year>2005</year><article-title>Does aneuploidy or mutation start cancer?</article-title><source>Science</source><volume>307</volume><fpage>41</fpage><pub-id pub-id-type="pmid">15637254</pub-id></citation></ref><ref id="pone.0002572-Ganem1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ganem</surname><given-names>NJ</given-names></name><name><surname>Storchova</surname><given-names>Z</given-names></name><name><surname>Pellman</surname><given-names>D</given-names></name></person-group><year>2007</year><article-title>Tetraploidy, aneuploidy and cancer.</article-title><source>Curr Opin Genet Dev</source><volume>17</volume><fpage>57</fpage><lpage>162</lpage></citation></ref><ref id="pone.0002572-Ganem2"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ganem</surname><given-names>NJ</given-names></name><name><surname>Pellman</surname><given-names>D</given-names></name></person-group><year>2007</year><article-title>Limiting the proliferation of polyploid cells.</article-title><source>Cell</source><volume>131</volume><fpage>437</fpage><lpage>440</lpage><pub-id pub-id-type="pmid">17981108</pub-id></citation></ref><ref id="pone.0002572-Ried1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ried</surname><given-names>T</given-names></name><name><surname>Heselmeyer-Haddad</surname><given-names>K</given-names></name><name><surname>Blegen</surname><given-names>H</given-names></name><name><surname>Schrock</surname><given-names>E</given-names></name><name><surname>Auer</surname><given-names>G</given-names></name></person-group><year>1999</year><article-title>Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation.</article-title><source>Genes Chromosomes Cancer</source><volume>25</volume><fpage>195</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">10379865</pub-id></citation></ref><ref id="pone.0002572-Duensing1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duensing</surname><given-names>S</given-names></name><name><surname>Munger</surname><given-names>K</given-names></name></person-group><year>2003</year><article-title>Centrosomes, genomic instability, and cervical carcinogenesis.</article-title><source>Crit Rev Eukaryot Gene Expr</source><volume>13</volume><fpage>9</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">12839094</pub-id></citation></ref><ref id="pone.0002572-Olaharski1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olaharski</surname><given-names>AJ</given-names></name><name><surname>Sotelo</surname><given-names>R</given-names></name><name><surname>Solorza-Luna</surname><given-names>G</given-names></name><name><surname>Gonsebatt</surname><given-names>ME</given-names></name><name><surname>Guzman</surname><given-names>P</given-names></name><etal/></person-group><year>2006</year><article-title>Tetraploidy and chromosomal instability are early events during cervical carcinogenesis.</article-title><source>Carcinogenesis</source><volume>27</volume><fpage>337</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">16123119</pub-id></citation></ref><ref id="pone.0002572-Ai1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ai</surname><given-names>H</given-names></name><name><surname>Barrera</surname><given-names>JE</given-names></name><name><surname>Meyers</surname><given-names>AD</given-names></name><name><surname>Shroyer</surname><given-names>KR</given-names></name><name><surname>Varella-Garcia</surname><given-names>M</given-names></name></person-group><year>2001</year><article-title>Chromosomal aneuploidy precedes morphological changes and supports multifocality in head and neck lesions.</article-title><source>Laryngoscope</source><volume>111</volume><fpage>1853</fpage><lpage>1858</lpage><pub-id pub-id-type="pmid">11801957</pub-id></citation></ref><ref id="pone.0002572-Cardoso1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cardoso</surname><given-names>J</given-names></name><name><surname>Molenaar</surname><given-names>L</given-names></name><name><surname>de Menezes</surname><given-names>RX</given-names></name><name><surname>van Leerdam</surname><given-names>M</given-names></name><name><surname>Rosenberg</surname><given-names>C</given-names></name><etal/></person-group><year>2006</year><article-title>Chromosomal instability in MYH- and APC-mutant adenomatous polyps.</article-title><source>Cancer Res</source><volume>66</volume><fpage>2514</fpage><lpage>2519</lpage><pub-id pub-id-type="pmid">16510566</pub-id></citation></ref><ref id="pone.0002572-Doak1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doak</surname><given-names>SH</given-names></name><name><surname>Jenkins</surname><given-names>GJ</given-names></name><name><surname>Parry</surname><given-names>EM</given-names></name><name><surname>Griffiths</surname><given-names>AP</given-names></name><name><surname>Baxter</surname><given-names>JN</given-names></name><etal/></person-group><year>2004</year><article-title>Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus-their association with aneuploidy and neoplastic progression.</article-title><source>Mutat Res</source><volume>547</volume><fpage>133</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">15013707</pub-id></citation></ref><ref id="pone.0002572-Pihan1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pihan</surname><given-names>GA</given-names></name><name><surname>Wallace</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Doxsey</surname><given-names>SJ</given-names></name></person-group><year>2003</year><article-title>Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas.</article-title><source>Cancer Res</source><volume>63</volume><fpage>398</fpage><lpage>1404</lpage></citation></ref><ref id="pone.0002572-Marx1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marx</surname><given-names>J</given-names></name></person-group><year>2002</year><article-title>Debate surges over the origins of genomic defects in cancer.</article-title><source>Science</source><volume>297</volume><fpage>44</fpage><lpage>546</lpage><pub-id pub-id-type="pmid">12098686</pub-id></citation></ref><ref id="pone.0002572-Fujiwara1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fujiwara</surname><given-names>T</given-names></name><name><surname>Bandi</surname><given-names>M</given-names></name><name><surname>Nitta</surname><given-names>M</given-names></name><name><surname>Ivanova</surname><given-names>EV</given-names></name><name><surname>Bronson</surname><given-names>RT</given-names></name><etal/></person-group><year>2005</year><article-title>Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells.</article-title><source>Nature</source><volume>437</volume><fpage>1043</fpage><lpage>1047</lpage><pub-id pub-id-type="pmid">16222300</pub-id></citation></ref><ref id="pone.0002572-Weaver1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>BA</given-names></name><name><surname>Silk</surname><given-names>AD</given-names></name><name><surname>Montagna</surname><given-names>C</given-names></name><name><surname>Verdier-Pinard</surname><given-names>P</given-names></name><name><surname>Cleveland</surname><given-names>DW</given-names></name></person-group><year>2007</year><article-title>Aneuploidy acts both oncogenically and as a tumor suppressor.</article-title><source>Cancer Cell</source><volume>11</volume><fpage>25</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">17189716</pub-id></citation></ref><ref id="pone.0002572-Dhanasekaran1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dhanasekaran</surname><given-names>SM</given-names></name><name><surname>Barrette</surname><given-names>TR</given-names></name><name><surname>Ghosh</surname><given-names>D</given-names></name><name><surname>Shah</surname><given-names>R</given-names></name><name><surname>Varambally</surname><given-names>S</given-names></name><etal/></person-group><year>2001</year><article-title>Delineation of prognostic biomarkers in prostate cancer.</article-title><source>Nature</source><volume>412</volume><fpage>822</fpage><lpage>826</lpage><pub-id pub-id-type="pmid">11518967</pub-id></citation></ref><ref id="pone.0002572-Valdman1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Valdman</surname><given-names>A</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Pang</surname><given-names>ST</given-names></name><name><surname>Ekman</surname><given-names>P</given-names></name><name><surname>Egevad</surname><given-names>L</given-names></name></person-group><year>2004</year><article-title>Pim-1 expression in prostatic intraepithelial neoplasia and human prostate cancer.</article-title><source>Prostate</source><volume>60</volume><fpage>367</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">15264249</pub-id></citation></ref><ref id="pone.0002572-Bachmann1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bachmann</surname><given-names>M</given-names></name><name><surname>Moroy</surname><given-names>T</given-names></name></person-group><year>2005</year><article-title>The serine/threonine kinase Pim-1.</article-title><source>Int J Biochem Cell Biol</source><volume>37</volume><fpage>726</fpage><lpage>730</lpage><pub-id pub-id-type="pmid">15694833</pub-id></citation></ref><ref id="pone.0002572-Roh1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roh</surname><given-names>M</given-names></name><name><surname>Gary</surname><given-names>B</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Said-Al-Naief</surname><given-names>N</given-names></name><name><surname>Tousson</surname><given-names>A</given-names></name><etal/></person-group><year>2003</year><article-title>Overexpression of the oncogenic kinase Pim-1 leads to genomic instability.</article-title><source>Cancer Res</source><volume>63</volume><fpage>8079</fpage><lpage>8084</lpage><pub-id pub-id-type="pmid">14678956</pub-id></citation></ref><ref id="pone.0002572-Roh2"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roh</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Abdulkadir</surname><given-names>SA</given-names></name></person-group><year>2005</year><article-title>Chromosomal instability induced by Pim-1 is passage-dependent and associated with dysregulation of cyclin B1.</article-title><source>J Biol Chem</source><volume>280</volume><fpage>40568</fpage><lpage>40577</lpage><pub-id pub-id-type="pmid">16221667</pub-id></citation></ref><ref id="pone.0002572-Jung1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>YJ</given-names></name><name><surname>Chae</surname><given-names>HC</given-names></name><name><surname>Seoh</surname><given-names>JY</given-names></name><name><surname>Ryu</surname><given-names>KH</given-names></name><name><surname>Park</surname><given-names>HK</given-names></name><etal/></person-group><year>2007</year><article-title>Pim-1 induced polyploidy but did not affect megakaryocytic differentiation of K562 cells and CD34&#x0002b; cells from cord blood.</article-title><source>Eur J Haematol</source><volume>78</volume><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">17313559</pub-id></citation></ref><ref id="pone.0002572-Lilly1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lilly</surname><given-names>M</given-names></name><name><surname>Sandholm</surname><given-names>J</given-names></name><name><surname>Cooper</surname><given-names>JJ</given-names></name><name><surname>Koskinen</surname><given-names>PJ</given-names></name><name><surname>Kraft</surname><given-names>A</given-names></name></person-group><year>1999</year><article-title>The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway.</article-title><source>Oncogene</source><volume>18</volume><fpage>4022</fpage><lpage>4031</lpage><pub-id pub-id-type="pmid">10435626</pub-id></citation></ref><ref id="pone.0002572-Uetake1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uetake</surname><given-names>Y</given-names></name><name><surname>Sluder</surname><given-names>G</given-names></name></person-group><year>2004</year><article-title>Cell cycle progression after cleavage failure: mammalian somatic cells do not possess a &#x0201c;tetraploidy checkpoint&#x0201d;.</article-title><source>J Cell Biol</source><volume>165</volume><fpage>09</fpage><lpage>615</lpage></citation></ref><ref id="pone.0002572-Thomas1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>M</given-names></name><name><surname>Massimi</surname><given-names>P</given-names></name><name><surname>Banks</surname><given-names>L</given-names></name></person-group><year>1996</year><article-title>HPV-18 E6 inhibits p53 DNA binding activity regardless of the oligomeric state of p53 or the exact p53 recognition sequence.</article-title><source>Oncogene</source><volume>13</volume><fpage>471</fpage><lpage>480</lpage><pub-id pub-id-type="pmid">8760288</pub-id></citation></ref><ref id="pone.0002572-Butz1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Butz</surname><given-names>K</given-names></name><name><surname>Shahabeddin</surname><given-names>L</given-names></name><name><surname>Geisen</surname><given-names>C</given-names></name><name><surname>Spitkovsky</surname><given-names>D</given-names></name><name><surname>Ullmann</surname><given-names>A</given-names></name><etal/></person-group><year>1995</year><article-title>Functional p53 protein in human papillomavirus-positive cancer cells.</article-title><source>Oncogene</source><volume>10</volume><fpage>927</fpage><lpage>936</lpage><pub-id pub-id-type="pmid">7898934</pub-id></citation></ref><ref id="pone.0002572-Hayward1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayward</surname><given-names>SW</given-names></name><name><surname>Haughney</surname><given-names>PC</given-names></name><name><surname>Rosen</surname><given-names>MA</given-names></name><name><surname>Greulich</surname><given-names>KM</given-names></name><name><surname>Weier</surname><given-names>HU</given-names></name><etal/></person-group><year>1998</year><article-title>Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model.</article-title><source>Differentiation</source><volume>63</volume><fpage>131</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">9697307</pub-id></citation></ref><ref id="pone.0002572-Duesberg2"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duesberg</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>R</given-names></name></person-group><year>2003</year><article-title>Multistep carcinogenesis: a chain reaction of aneuploidizations.</article-title><source>Cell Cycle</source><volume>2</volume><fpage>202</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">12734426</pub-id></citation></ref><ref id="pone.0002572-Forsslund1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forsslund</surname><given-names>G</given-names></name><name><surname>Zetterberg</surname><given-names>A</given-names></name></person-group><year>1990</year><article-title>Ploidy level determinations in high-grade and low-grade malignant variants of prostatic carcinoma.</article-title><source>Cancer Res</source><volume>50</volume><fpage>4281</fpage><lpage>4285</lpage><pub-id pub-id-type="pmid">1694718</pub-id></citation></ref><ref id="pone.0002572-Deitch1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deitch</surname><given-names>AD</given-names></name><name><surname>Miller</surname><given-names>GJ</given-names></name><name><surname>deVere White</surname><given-names>RW</given-names></name></person-group><year>1993</year><article-title>Significance of abnormal diploid DNA histograms in localized prostate cancer and adjacent benign prostatic tissue.</article-title><source>Cancer</source><volume>72</volume><fpage>1692</fpage><lpage>1700</lpage><pub-id pub-id-type="pmid">7688657</pub-id></citation></ref><ref id="pone.0002572-Mendelin1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mendelin</surname><given-names>J</given-names></name><name><surname>Grayson</surname><given-names>M</given-names></name><name><surname>Wallis</surname><given-names>T</given-names></name><name><surname>Visscher</surname><given-names>DW</given-names></name></person-group><year>1999</year><article-title>Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization.</article-title><source>Lab Invest</source><volume>79</volume><fpage>387</fpage><lpage>393</lpage><pub-id pub-id-type="pmid">10211991</pub-id></citation></ref><ref id="pone.0002572-Visscher1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Visscher</surname><given-names>DW</given-names></name><name><surname>Wallis</surname><given-names>TL</given-names></name><name><surname>Crissman</surname><given-names>JD</given-names></name></person-group><year>1996</year><article-title>Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics.</article-title><source>Cancer</source><volume>77</volume><fpage>315</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">8625240</pub-id></citation></ref><ref id="pone.0002572-Ottesen1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ottesen</surname><given-names>GL</given-names></name><name><surname>Christensen</surname><given-names>IJ</given-names></name><name><surname>Larsen</surname><given-names>JK</given-names></name><name><surname>Kerndrup</surname><given-names>GB</given-names></name><name><surname>Hansen</surname><given-names>B</given-names></name><etal/></person-group><year>1995</year><article-title>DNA aneuploidy in early breast cancer.</article-title><source>Br J Cancer</source><volume>72</volume><fpage>832</fpage><lpage>839</lpage><pub-id pub-id-type="pmid">7547228</pub-id></citation></ref><ref id="pone.0002572-Elenbaas1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elenbaas</surname><given-names>B</given-names></name><name><surname>Spirio</surname><given-names>L</given-names></name><name><surname>Koerner</surname><given-names>F</given-names></name><name><surname>Fleming</surname><given-names>MD</given-names></name><name><surname>Zimonjic</surname><given-names>DB</given-names></name><etal/></person-group><year>2001</year><article-title>Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.</article-title><source>Genes Dev</source><volume>15</volume><fpage>50</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">11156605</pub-id></citation></ref><ref id="pone.0002572-Woo1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>RA</given-names></name><name><surname>Poon</surname><given-names>RY</given-names></name></person-group><year>2004</year><article-title>Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.</article-title><source>Genes Dev</source><volume>18</volume><fpage>317</fpage><lpage>1330</lpage></citation></ref><ref id="pone.0002572-Li1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Dang</surname><given-names>CV</given-names></name></person-group><year>1999</year><article-title>c-Myc overexpression uncouples DNA replication from mitosis.</article-title><source>Mol Cell Biol</source><volume>19</volume><fpage>5339</fpage><lpage>5351</lpage><pub-id pub-id-type="pmid">10409725</pub-id></citation></ref><ref id="pone.0002572-Dikovskaya1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dikovskaya</surname><given-names>D</given-names></name><name><surname>Schiffmann</surname><given-names>D</given-names></name><name><surname>Newton</surname><given-names>IP</given-names></name><name><surname>Oakley</surname><given-names>A</given-names></name><name><surname>Kroboth</surname><given-names>K</given-names></name><etal/></person-group><year>2007</year><article-title>Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis.</article-title><source>J Cell Biol</source><volume>176</volume><fpage>83</fpage><lpage>195</lpage></citation></ref><ref id="pone.0002572-Caldwell1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caldwell</surname><given-names>CM</given-names></name><name><surname>Green</surname><given-names>RA</given-names></name><name><surname>Kaplan</surname><given-names>KB</given-names></name></person-group><year>2007</year><article-title>APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice.</article-title><source>J Cell Biol</source><volume>178</volume><fpage>109</fpage><lpage>1120</lpage></citation></ref><ref id="pone.0002572-Sagulenko1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sagulenko</surname><given-names>E</given-names></name><name><surname>Savelyeva</surname><given-names>L</given-names></name><name><surname>Ehemann</surname><given-names>V</given-names></name><name><surname>Sagulenko</surname><given-names>V</given-names></name><name><surname>Hofmann</surname><given-names>W</given-names></name><etal/></person-group><year>2007</year><article-title>Suppression of polyploidy by the BRCA2 protein.</article-title><source>Cancer Lett</source><volume>257</volume><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">17686574</pub-id></citation></ref><ref id="pone.0002572-Wang1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>YX</given-names></name><name><surname>Qiao</surname><given-names>W</given-names></name><name><surname>Tominaga</surname><given-names>Y</given-names></name><name><surname>Ouchi</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation.</article-title><source>Oncogene</source><volume>25</volume><fpage>148</fpage><lpage>7158</lpage><pub-id pub-id-type="pmid">16799631</pub-id></citation></ref><ref id="pone.0002572-Yin1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>XY</given-names></name><name><surname>Grove</surname><given-names>L</given-names></name><name><surname>Datta</surname><given-names>NS</given-names></name><name><surname>Long</surname><given-names>MW</given-names></name><name><surname>Prochownik</surname><given-names>EV</given-names></name></person-group><year>1999</year><article-title>C-myc overexpression and p53 loss cooperate to promote genomic instability.</article-title><source>Oncogene</source><volume>18</volume><fpage>177</fpage><lpage>1184</lpage></citation></ref><ref id="pone.0002572-Minn1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minn</surname><given-names>AJ</given-names></name><name><surname>Boise</surname><given-names>LH</given-names></name><name><surname>Thompson</surname><given-names>CB</given-names></name></person-group><year>1996</year><article-title>Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage.</article-title><source>Genes Dev</source><volume>10</volume><fpage>2621</fpage><lpage>2631</lpage><pub-id pub-id-type="pmid">8895663</pub-id></citation></ref><ref id="pone.0002572-Andreassen1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andreassen</surname><given-names>PR</given-names></name><name><surname>Lohez</surname><given-names>OD</given-names></name><name><surname>Lacroix</surname><given-names>FB</given-names></name><name><surname>Margolis</surname><given-names>RL</given-names></name></person-group><year>2001</year><article-title>Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1.</article-title><source>Mol Biol Cell</source><volume>12</volume><fpage>315</fpage><lpage>1328</lpage></citation></ref><ref id="pone.0002572-Castedo1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castedo</surname><given-names>M</given-names></name><name><surname>Coquelle</surname><given-names>A</given-names></name><name><surname>Vivet</surname><given-names>S</given-names></name><name><surname>Vitale</surname><given-names>I</given-names></name><name><surname>Kauffmann</surname><given-names>A</given-names></name><etal/></person-group><year>2006</year><article-title>Apoptosis regulation in tetraploid cancer cells.</article-title><source>Embo J</source><volume>25</volume><fpage>2584</fpage><lpage>2595</lpage><pub-id pub-id-type="pmid">16675948</pub-id></citation></ref><ref id="pone.0002572-Aho1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aho</surname><given-names>TL</given-names></name><name><surname>Sandholm</surname><given-names>J</given-names></name><name><surname>Peltola</surname><given-names>KJ</given-names></name><name><surname>Mankonen</surname><given-names>HP</given-names></name><name><surname>Lilly</surname><given-names>M</given-names></name><etal/></person-group><year>2004</year><article-title>Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site.</article-title><source>FEBS Lett</source><volume>571</volume><fpage>43</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">15280015</pub-id></citation></ref><ref id="pone.0002572-Li2"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Sonik</surname><given-names>A</given-names></name><name><surname>Stindl</surname><given-names>R</given-names></name><name><surname>Rasnick</surname><given-names>D</given-names></name><name><surname>Duesberg</surname><given-names>P</given-names></name></person-group><year>2000</year><article-title>Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy.</article-title><source>Proc Natl Acad Sci U S A</source><volume>97</volume><fpage>236</fpage><lpage>3241</lpage></citation></ref><ref id="pone.0002572-Abdulkadir1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abdulkadir</surname><given-names>SA</given-names></name><name><surname>Qu</surname><given-names>Z</given-names></name><name><surname>Garabedian</surname><given-names>E</given-names></name><name><surname>Song</surname><given-names>SK</given-names></name><name><surname>Peters</surname><given-names>TJ</given-names></name><etal/></person-group><year>2001</year><article-title>Impaired prostate tumorigenesis in Egr1-deficient mice.</article-title><source>Nat Med</source><volume>7</volume><fpage>101</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">11135623</pub-id></citation></ref><ref id="pone.0002572-Mogal1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mogal</surname><given-names>AP</given-names></name><name><surname>van der Meer</surname><given-names>R</given-names></name><name><surname>Crooke</surname><given-names>PS</given-names></name><name><surname>Abdulkadir</surname><given-names>SA</given-names></name></person-group><year>2007</year><article-title>Haploinsufficient prostate tumor suppression by Nkx3.1: a role for chromatin accessibility in dosage-sensitive gene regulation.</article-title><source>J Biol Chem</source><volume>282</volume><fpage>25790</fpage><lpage>25800</lpage><pub-id pub-id-type="pmid">17602165</pub-id></citation></ref><ref id="pone.0002572-Karpf1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karpf</surname><given-names>AR</given-names></name><name><surname>Matsui</surname><given-names>S</given-names></name></person-group><year>2005</year><article-title>Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells.</article-title><source>Cancer Res</source><volume>65</volume><fpage>635</fpage><lpage>8639</lpage></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>Supported by National Cancer Institute grant RO1CA123484. Sponsors had no role in the design, collection, analysis or interpretation of data or preparation, review or approval of the manuscript.</p></fn></fn-group></back></article> 